UTI Healthcare Fund Direct-Growth
NAV
₹335.5861
as on 18 Sep 2025, 11:12 PM
₹1.2685(0.38%)
Last Change
Schemes Managed By
Scheme Information
UTI Healthcare Fund Direct-Growth
as of 31 Aug 2025, 05:30 AM
₹1,118.41 Cr
1.29%
0.64%
Open-End
Growth
Exit load of 1% if redeemed within 30 days.
BSE Healthcare Total Return Index
View
Sectors Holding in this Mutual Fund
Healthcare
99.35%
₹1,111.12 Cr
Others
0.65%
₹7.27 Cr
Healthcare
99.35%
₹1,111.12 Cr
Others
0.65%
₹7.27 Cr
Sun Pharmaceutical Industries Ltd.
10.44%
₹116.76 Cr
Cipla Ltd.
5.52%
₹61.74 Cr
Dr. Reddy's Laboratories Ltd.
4.66%
₹52.12 Cr
Procter & Gamble Health Ltd.
4.34%
₹48.54 Cr
Ajanta Pharma Ltd.
4.09%
₹45.74 Cr
Others
70.95%
₹793.51 Cr
Sun Pharmaceutical Industries Ltd.
10.44%
₹116.76 Cr
Cipla Ltd.
5.52%
₹61.74 Cr
Dr. Reddy's Laboratories Ltd.
4.66%
₹52.12 Cr
Procter & Gamble Health Ltd.
4.34%
₹48.54 Cr
Ajanta Pharma Ltd.
4.09%
₹45.74 Cr
Others
70.95%
₹793.51 Cr
Funds in this Category
This fund's returns: 27.81%
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
Min. Investment
₹100
30.47
Category Returns
20.02%
30.47%
3Y Returns
30.47 %
SBI Healthcare Opportunities Fund Direct Plan-Growth
Min. Investment
₹500
27.49
Category Returns
20.02%
30.47%
3Y Returns
27.49 %
DSP Healthcare Fund Direct - Growth
Min. Investment
₹100
26.38
Category Returns
20.02%
30.47%
3Y Returns
26.38 %
About UTI Healthcare Fund Direct-Growth
UTI Healthcare Fund Direct-Growth scheme return performance in last 1 year is 3.70%, in last 3 years is 109.06% and 600.58% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Details
| AUM: | ₹1,118.41 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
UTI Mutual Fund
Address
Investment Performance
₹ 1,00,000
would have given a return of
₹1,10,871
₹1,21,647
₹2,02,907
₹2,09,057
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
Profit (absolute return)
₹1,09,057
109.06%
Investment Returns
Scheme Riskometer
Investors understand that their principal will be at very high risk
